Lian Beng - White Spinning Top

The White Spinning Top is a single candlestick pattern. Its shape is a small white body with upper and lower shadows that have a greater length than the body's length.

The real body of the pattern is white and small. The upper and lower shadows are longer than the real body's length.

The market moves higher and then sharply lower, or vice versa. It then closes above the opening price creating a white body. This represents complete indecision between the bulls and the bears. The actual length of the shadows is not important. The small body relative to the shadows is what makes the spinning top.

Important Factors:

If a White Spinning Top is observed after a long rally or a long white candlestick, this implies weakness among the bulls and it is a warning about a potential change or interruption in trend.
If a White Spinning Top is observed after a long decline or a long black candlestick, this implies weakness among the bears and it is a warning about a potential change or interruption in trend.
Like most other single candlestick patterns, the White Spinning Top has low reliability. It reflects only one day's trading and can be interpreted both as a continuation and a reversal pattern. This candlestick needs to be used with other candlesticks for a healthier confirmation of a trend.

http://www.candlesticker.com/Cs03.asp

Will probably continue to trade between 67 - 55 cents until the bulls or bears gain victory.

KTL Global hourly sandwich between support and resistance

Trap between resistance zone 62.5 - 58 cents and support zone 52.5 - 50 cents.

Bulls fought back from 45 cents low and are making another attempt to clear the resistance zone.

Monitor for breakout

First Resources 30 mins chart Neckline becomes support again

Monitor 200 EMA and neckline support

first state-of-the-art biotech cluster in India

Genome Valley

Genome Valley is the first state-of-the-art biotech cluster in India for life science research, training and manufacturing activities. Advantages in Bio-pharma sector in Andhra Pradesh, enable more than hundred biotech companies to flourish in this sector, which makes Genome Valley the most fertile soil that can foster growth at a staggering pace!

R&D ADVANTAGE

ICICI Knowledge Park is located in a 200 acre campus in the heart of Genome Valley. Hyderabad. This is the first state-of-the-art biotech cluster in India for life sciences research, training, collaboration and manufacturing activities. Spread over 600 sq. kms. around the ICICI Knowledge Park, the SP Biotech Park and the ICRISAT Agri-business Incubator, the Genome Valley provides world-class infrastructure facilities to over 100 biotech companies. A large number of R&D and academic institutions in and around the biotech cluster contribute to the knowledge and talent pool.

http://www.iciciknowledgepark.com/icicikp/iciciinnerfiles/genomevalley.htm

Genome Valley

Genome Valley is a biotech cluster setup near Hyderabad, India to provide world-class facilities to over 100 biotech companies. It is a 200 acre Knowledge Park(KP) which is a joint initiative of ICICI Bank[1] and the Andhra Pradesh government. KP is the first of its kind knowledge-nurturing centre for the Indian companies and a knowledge gateway for multinational companies. Spread over 600 km², covering the mandals of Shamirpet, Medchal, Keesra and Uppal in Ranga Reddy District, the Genome Valley has developed as a natural cluster for biotech research, training and manufacturing activities.

In a recent development, the world's first ever "Centre of Excellence in Medical Bioinformatics"[2] was inaugurated at the Gandipet campus of CDFD, Hyderabad by the President of India. The presence of some of the leading institutions (see List of institutions based in Hyderabad India), have proved to be strong partners for Andhra’s biotech sector.

US Pharmacopeia(USP) has opened a laboratory in the Genome Valley which is only one outside Washington,US.[3]

The Knowledge Park has five Innovation Corridors on its agenda. The first phase of Innovation Corridor I, comprising 10 laboratories, each of about 3,000 ft² (300 m²), is operational and fully occupied. The second phase of Innovation Corridor I, comprising 16 laboratory modules of 1,700 ft² (170 m²) each, is ready for operation.

Genome Valley BioCluster comprises the following:

Shapoorji Pallonji Biotech Park,
ICICI Knowledge Park,
Bharat Biotech Park,
Shanta Biotechnics,
Godrej Plant Biotech Ltd,
Biological E Ltd,
Krebs Biochemicals,
Nuziveedu Seed Co. Ltd.
GVK Biosciences Private Ltd.
Jupiter Orga,
Metchnikoff Biosystems,
Satyam Forest Research Centre,
Haritha Biotech and Plantations,
AG Biotech Laboratories (India) Ltd,
Mericlone Biotech Private Ltd

http://en.wikipedia.org/wiki/Genome_Valley

Amgen

Amgen Inc. (NASDAQ: AMGN, SEHK: 4332) is an international biotechnology company headquartered in the Newbury Park section of Thousand Oaks, California. Located in the Conejo Valley, it is one of the top corporations in the Tech Coast area. Amgen is the largest independent biotech firm, with approx. 14,000 staff members including the 150 Allied-Barton Security staff and A-post personnel in 2007. Its products include EPOGEN, ARANESP, ENBREL, Kineret, Neulasta, NEUPOGEN, and Sensipar / Mimpara. EPOGEN and NEUPOGEN (the company's first products on the market) were the two most successful biopharmaceutical products at the time of their respective releases.

BusinessWeek ranked Amgen fourth on the S&P 500 for being the most "future-oriented" of those five hundred corporations.[2] BusinessWeek ostensibly calculated the ratio of research and development spending, combined with capital spending, to total outlays; Amgen had the fourth highest ratio, at 506:1000.

Amgen is the largest employer in Thousand Oaks and second only to the United States Navy in terms of number of people employed in Ventura County. Amgen is also a member of the Pennsylvania Bio commerce organization.[3]

With plans to expand into a new campus under construction in South San Francisco, Amgen abruptly halted construction on the plans and instead put the 365,000 square feet (33,900 m²) of new space on the sublease market.[4]

The word AMGen is a portmanteau of the company's original name, Applied Molecular Genetics, which became the official name of the company in 1983 (three years after incorporation and coincident with its initial public offering). The company's first chief executive officer, from 1980, was George B. Rathmann, followed by Gordon M. Binder in 1988, followed by Kevin W. Sharer in 2000. The company has made at least five major corporate acquisitions.

Acquisition history

1994 - Synergen, Inc.
2000 - Kinetix Pharmaceuticals, Inc.
2002 - Immunex Corporation
2004 - Tularik, Inc.
2006 - Abgenix, Inc.
2006 - Avidia, Inc.
2007 - Ilypsa, Inc.
2007 - Alantos Pharmaceuticals Holdings, Inc.

Products

As of September 27, 2006, Amgen had nine approved drugs for fourteen conditions (conditions lists are highly generalized; see each article for more detail):

Aranesp (darbepoetin alfa) (for anemia)
Enbrel (Etanercept) (for various forms of arthritis)
Epogen (Epoetin) (for anemia)
Kepivance (Palifermin) (for oral mucositis)
Kineret (Anakinra) (for rheumatoid arthritis)
Neupogen (Granulocyte-Colony Stimulating Factor or "Filgrastim") (for neutropenia)
Neulasta (PEG Granulocyte-Colony Stimulating Factor or "PEG-Filgrastim") (for neutropenia)
Vectibix (Panitumumab) (for colon cancer)
Sensipar (Cinacalcet) (for Secondary hyperparathyroidism, a mineral metabolism complication common in patients with kidney failure)

In other drug discovery phases (Phases I, II, III and in preclinical development), the company has twenty-three pharmacologic agents for twenty-eight conditions; nineteen of the candidates are not currently approved for any indication. Precedent within the pharmaceutical industry suggests that many of these candidate drugs will not emerge as marketed approved drugs.

http://en.wikipedia.org/wiki/Amgen

First Resources 30 mins chart Neckline Resistance

Price closing on 200EMA and must move above this resistance.

Monitor neckline resistance and blue dotted line downtrend resistance line.